Figure 2 | Scientific Reports

Figure 2

From: Peptide VSAK maintains tissue glucose uptake and attenuates pro-inflammatory responses caused by LPS in an experimental model of the systemic inflammatory response syndrome: a PET study

Figure 2

Systemic [18F]FDG uptake after the administration of LPS (450 ng/kg) and/or peptide VSAK (60 µg/kg). (A) Schematic representation showing the administration of treatments and PET acquisition procedures. (B) PET images showing the global 18FDG uptake of representative experimental rabbits during the 90-min acquisition time. (C) The quantitative analysis expressed as a percentage of the injected dose per gram of tissue (%ID/g). (D) percentage of injected dose per organ (%ID/organ). Control, VSAK; LPS and VSAK + LPS groups, n = 3. Differences assessed using two-way ANOVA with Tukey’s multiple comparison tests.

Back to article page